Ultomiris Drug Market 2025: Advancing Rare Disease Treatment Through Long-Acting Complement Inhibition
Ultomiris Drug Market 2025: Advancing Rare Disease Treatment Through Long-Acting Complement Inhibition The global Ultomiris Drug Market is witnessing robust growth, driven by the increasing prevalence of rare complement-mediated diseases, expanding regulatory approvals, and growing adoption of long-acting biologic therapies. The market is projected to grow from USD 5.2 billion in...
0 Commentarii 0 Distribuiri 3 Views 0 previzualizare
BuzzingAbout https://www.buzzingabout.com